Halozyme Therapeutics Inc

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Halozyme Therapeutics Inc (HALO) SEC filings

Halozyme Therapeutics Inc (HALO) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported HALO revenue for 2025-12-31 was $1.40B. Net income was $316.9M. Revenue was up 37.6% from 2024-12-31 to 2025-12-31. HALO currently screens at market cap $7.10B. The HALO filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Halozyme Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for HALO — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

HALO SEC filings FAQ

What is the latest HALO SEC filing?

The latest cached Halozyme Therapeutics Inc (HALO) filing on this page is 8-K · Sep 30, 2026. Filings: https://lician.com/sec/halo

What is the latest HALO filing accession number?

The latest cached Halozyme Therapeutics Inc (HALO) accession number on this page is 0001159036-26-000128. Filing: https://lician.com/sec/halo/0001159036-26-000128

Which item code is on the latest HALO filing?

Cached item code on the latest Halozyme Therapeutics Inc (HALO) 8-K is 5.02.

How many HALO SEC filings are listed on this page?

This page lists 5 cached Halozyme Therapeutics Inc (HALO) SEC filings. Filings: https://lician.com/sec/halo

What events are listed on the HALO SEC page?

Cached event headlines on this Halozyme Therapeutics Inc (HALO) SEC page: "HALO earnings". Events: https://lician.com/sec/halo

What are HALO's latest revenue and net income?

Latest cached Halozyme Therapeutics Inc (HALO) revenue for Dec 31, 2025 was $1.40B. Net income was $316.9M. Statements: https://lician.com/financials/halo